Mesothelial markers in high-grade breast carcinoma (Q42497492)

1 November 2017

Mesothelial markers in high-grade breast carcinoma (English)

1 reference

1 November 2017

3

1 reference

1 November 2017

Edwina E Duhig

1

1 reference

PubMed ID

22092407

1 November 2017

Lydia Kalpakos

series ordinal

2

1 reference

PubMed ID

22092407

1 November 2017

Belinda E Clarke

series ordinal

4

1 reference

1 November 2017

1 November 2011

1 reference

1 November 2017

1 reference

1 November 2017

59

1 reference

1 November 2017

5

1 reference

1 November 2017

957-964

1 reference

Triple-Negative Breast Cancer

1 November 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04036.X

Breast cancers with brain metastases are more likely to be estrogen receptor negative, express the basal cytokeratin CK5/6, and overexpress HER2 or EGFR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04036.X

Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04036.X

Basal-like grade III invasive ductal carcinoma of the breast: patterns of metastasis and long-term survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04036.X

Coordinated expression of ER, PR and HER2 define different prognostic subtypes among poorly differentiated breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04036.X

Expression of luminal and basal cytokeratins in human breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04036.X

Evaluation of a panel of molecular markers for the diagnosis of malignant serous effusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04036.X

WT1 mutation in malignant mesothelioma and WT1 immunoreactivity in relation to p53 and growth factor receptor expression, cell-type transition, and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04036.X

Differential diagnosis of serous papillary carcinoma of the gynaecological tract and basal breast carcinoma: an immunohistochemical approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04036.X

Plasma thrombomodulin activity, tissue factor activity and high levels of circulating procoagulant phospholipid as prognostic factors for acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04036.X

Overexpression and altered glycosylation of MUC1 in malignant mesothelioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04036.X

10.1111/J.1365-2559.2011.04036.X

21 January 2018

Identifiers

DOI

1 reference

1 November 2017

1 reference

PubMed ID

22092407